Get the app!
Back to Companies

AgomAb Therapeutics NV

AGMBNasdaqCIK: 0002020932

Recent Form 4 activity at AgomAb Therapeutics NV (AGMB) spans 12 filings across 5 insiders (all of them on the buy side). Purchases total $620.0K against $0 in sales — heavily weighted toward buying, for a net purchase of $620.0K. Epstein David R (Director) is the most active by dollar volume, and the single largest transaction was $103.5K by Epstein David R. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.

Total Volume
$620.0K
Purchases
$620.0K
Sales
$0
Unique Insiders
5

Recent Insider Trades

12 loaded
Nov 19AGMB
AgomAb Therapeutics NV
Epstein David RDirectorBuy$27.9K
Nov 16AGMB
AgomAb Therapeutics NV
Epstein David RDirectorBuy$88.7K
Nov 6AGMB
AgomAb Therapeutics NV
Epstein David RDirectorBuy$103.5K
Oct 22AGMB
AgomAb Therapeutics NV
Epstein David RDirectorBuy$88.8K
Oct 9AGMB
AgomAb Therapeutics NV
Epstein David RDirectorBuy$44.5K
Oct 7AGMB
AgomAb Therapeutics NV
Kemula Pierre Thadee VictorChief Financial OfficerBuy$85.9K
Oct 7AGMB
AgomAb Therapeutics NV
Epstein David RDirectorBuy$86.3K
Oct 7AGMB
AgomAb Therapeutics NV
Knotnerus Tim JasperChief Executive Officer, DirectorBuy$94.4K
Sep 15AGMB
AgomAb Therapeutics NV
Garcia MarinoDirectorAward$0
Sep 15AGMB
AgomAb Therapeutics NV
Garcia MarinoDirectorOther$0
Sep 15AGMB
AgomAb Therapeutics NV
Patel NaimishDirectorOther$0
Sep 15AGMB
AgomAb Therapeutics NV
Patel NaimishDirectorAward$0

12 filings